Steward Partners Investment Advisory’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $179K | Buy |
|
|||||
|
2025
Q2 | $96.9K | Buy |
|
|||||
|
2025
Q1 | $49K | Buy |
|
|||||
|
2024
Q4 | $33.9K | Sell |
|
|||||
|
2024
Q3 | $44.5K | Sell |
|
|||||
|
2024
Q2 | $61.5K | Sell |
|
|||||
|
2024
Q1 | $105K | Sell |
|
|||||
|
2023
Q4 | $125K | Buy |
|
|||||
|
2023
Q3 | $90.1K | Buy |
|
|||||
|
2023
Q2 | $110K | Sell |
|
|||||
|
2023
Q1 | $89.9K | Sell |
|
|||||
|
2022
Q4 | $81.6K | Buy |
|
|||||
|
2022
Q3 | $125K | Sell |
|
|||||
|
2022
Q2 | $118K | Buy |
|
|||||
|
2022
Q1 | $113K | Buy |
|
|||||
|
2021
Q4 | $53K | Sell |
|
|||||
|
2021
Q3 | $118K | Sell |
|
|||||
|
2021
Q2 | $287K | Sell |
|
|||||
|
2021
Q1 | $506K | Buy |
|
|||||
|
2020
Q4 | $140K | Buy |
|
|||||
|
2020
Q3 | $31K | Buy |
|
|||||
|
2020
Q2 | $22K | Hold |
|
|||||
|
2020
Q1 | $12K | Hold |
|
|||||
|
2019
Q4 | $18K | Hold |
|
|||||
|
2019
Q3 | $12K | Hold |
|
|||||
|
2019
Q2 | $14K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $13K | Buy |
|
|||||
|
2018
Q2 | $6K | Hold |
|
|||||
|
2018
Q1 | $4K | Buy |
|